Clinical trial
Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing Insert
NCT07391592 is registered in ClinicalTrials.gov with MicroPort Orthopedics Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing Insert
- Lead sponsor
- MicroPort Orthopedics Inc.
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- August 18, 2025
- Completion date
- December 31, 2032
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
arthritis knee, avascular necrosis, joint diseases, osteoarthitis, rheumatoid arthritis of knee